HEPCFIX 60 is used for the treatment of chronic hepatitis C, particularly in combination with other antiviral drugs. Daclatasvir blocks certain proteins of the hepatitis C virus that are necessary for its replication, thereby reducing viral load and supporting the body in fighting the infection. The drug is taken orally and helps improve liver condition.
The product is used for:
Chronic hepatitis C
Viral load reduction in hepatitis C
Hepatitis C treatment in combination with other antiviral drugs as part of a comprehensive therapy
HEPCFIX 60 is taken orally, 1 tablet (60 mg) daily. The drug can be taken with or without food, depending on the doctor's instructions. Treatment duration and dosage may be adjusted based on the patient's condition and viral load. The drug should not be used without consultation with a doctor.
Contraindications:
Hypersensitivity to daclatasvir or any other component of the product
Severe liver disease, such as decompensated cirrhosis
Pregnancy and breastfeeding (under medical supervision)
Concurrent use with certain other drugs (e.g., drugs that may cause interaction)
Side Effects:
Headache
Fatigue, weakness
Nausea, digestive upset
Skin irritation, rash
Sleep disturbances
Muscle pain
